
Sign up to save your podcasts
Or


In the first segment, Dr. Jason Crowell talks with Dr. Daniel Hartung about his paper on the effect of generic glatiramer acetate on the reduction of MS costs. In the second part of the podcast, Dr. Jason Crowell speaks with Dr. Brian Callaghan about his paper—also from the March 31st issue of Neurology—on the association between out-of-pocket costs and adherence to common neurologic medications.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week's Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
By American Academy of Neurology4.7
285285 ratings
In the first segment, Dr. Jason Crowell talks with Dr. Daniel Hartung about his paper on the effect of generic glatiramer acetate on the reduction of MS costs. In the second part of the podcast, Dr. Jason Crowell speaks with Dr. Brian Callaghan about his paper—also from the March 31st issue of Neurology—on the association between out-of-pocket costs and adherence to common neurologic medications.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week's Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.

317 Listeners

497 Listeners

51 Listeners

3,340 Listeners

12 Listeners

1,150 Listeners

23 Listeners

194 Listeners

512 Listeners

134 Listeners

366 Listeners

190 Listeners

372 Listeners

318 Listeners

81 Listeners